Form 8-K - Current report:
SEC Accession No. 0001193125-13-444675
Filing Date
2013-11-18
Accepted
2013-11-18 07:45:30
Documents
1
Period of Report
2013-11-18
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d631585d8k.htm 8-K 16054
  Complete submission text file 0001193125-13-444675.txt   17275
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52089 | Film No.: 131225432
SIC: 3841 Surgical & Medical Instruments & Apparatus